Shows
People of Pathology PodcastEpisode 201: Ashley Kalinauskas - How Torigen is Innovating Veterinary Oncology With ImmunotherapyMy guest today is Ashley Kalinauskas, CEO of Torigen Pharmaceuticals.
What we discuss with Ashley:
How her graduate research at Notre Dame led to the founding of Torigen Pharmaceuticals.
Their approach provides an alternative to chemotherapy by using immunotherapy.
The company aims to make cancer treatment more accessible and affordable for pet owners.
Promising results have been seen in aggressive cancers like hemangiosarcoma.
How Torigen is utilizing digital pathology with the Concentriq platform to improve cancer diagnostics.
Torigen is conducting research into additional applications, including equine and exotic animal cancers.
Studying spontaneous cancer in pets provides...2025-03-3145 min
Calling All CreaturesCalling All Creatures Presents Torigen Pharmaceuticals Pet Cancer VaccinesHey everyone! So just wanted to announce my next podcast which I think is another important one as it is also dealing with canine cancers. I'm going to be talking with Ashley Kalinauskas, the Co-founder and CEO of Torigen Pharmaceuticals. They are researching and creating vaccines that help fight different types of canine cancer. What they're doing with this research is so important to help our pets when they get cancer diagnoses. If you'd like to learn more about Torigen and what they're doing please tune in!2024-11-221h 02
All Things Veterinary PodcastAdvances in the fight against cancer in animalsMore than four million dogs and four million cats are expected to be diagnosed with cancer this year. Jimmy talks with Ashley Kalinauskas, the founder and CEO of Torigen Pharmaceuticals, a company that’s leading the way in advances in the fight against animal cancer.Show notes:Contact the podcast team > AllThingsVetPodcast@pattersonvet.comLearn more about Patterson>pattersonvet.com2024-11-2126 min
Biotech LifeStream: Flowing with the Innovators of TomorrowAshley Kalinauskas - CEO of Torigen Pharmaceuticals: Personalized Cancer Vaccine and the Potential of MicrobiomeAshley is the CEO and founder of Torigen Pharmaceuticals, a company born out of her graduate thesis at the University of Notre Dame. She holds a degree in Pathobiology from the University of Connecticut (2012) and completed her Master’s at Notre Dame in 2013. Torigen focuses on an experimental autologous cancer vaccine developed from the research of Dr. Mark Suckow, one of her professors at Notre Dame.Ashley has received several prestigious accolades, including being named to Forbes 30 Under 30 in 2020, the Animal Health Innovation USA Award in 2021, Notre Dame’s Domer Dozen in 2021, and the Hartford Business Journal’s 2023...2024-09-2130 min
The Harvest PodcastCEO INTERVIEW: Unleashing Hope: How One Entrepreneur's Pet Project Is Revolutionizing Animal Cancer CareIn this episode of The Harvest, host Carmel Fisher interviews Ashley Kalinauskas, founder and CEO of Torigen Pharmaceuticals.Ashley discusses her journey from graduate school to creating a personalized cancer therapy for pets.She explains how their innovative autologous cancer vaccine works, shares success rates, and talks about navigating funding rounds as a female entrepreneur in biotech.Ashley also offers insights into team building, industry challenges, and future developments in animal health care. The conversation touches on the growing demand for advanced veterinary care and Torigen's plans for expansion into other areas of...2024-09-1726 min
Tenacity with Sonia C.Biotech Startup Revolutionizing for Pet Cancer TreatmentsIn this episode of "Tenacity with Sonia C," host Sonia Couto sits down with Ashley Kalinauskas, the founder and CEO of Torigen Pharmaceuticals.Ashley shares her incredible journey from graduate student to biotech entrepreneur, discussing how her groundbreaking research at the University of Notre Dame led to the creation of a personalized cancer vaccine for pets. They delve into the challenges of transitioning from academic research to a full-fledged startup, the innovative approaches Torigen is taking in veterinary oncology, and the importance of immunotherapy in improving the quality of life for pets with cancer.Ashley...2024-07-2327 min
Women's Biz GlobalWomen's Biz Podcast Episode 183: Annie Gibbins with Guest Ashley KalinauskasPioneering Pet Health: Ashley Kalinauskas' Journey with Torigen
Welcome!
Today we're thrilled to have Ashley Kalinauskas, a visionary leader at the forefront of biotechnology. Ashley is the founder and CEO of Torigen, a remarkable company dedicated to enhancing the lives of our beloved pets.
Through Torigen's groundbreaking product, VetiVax, a personalised cancer vaccine, Ashley has redirected cutting-edge research originally intended for humans towards transforming the lives of countless dogs, cats, and horses post-cancer diagnosis.
Join us as we delve into Ashley's inspiring journey, from a concept in the lab to spearheading...2024-07-0327 min
Vetsplanation: Pet Health SimplifiedRevolutionary Pet Cancer Vaccine Revealed!Send us a textDiscover the groundbreaking advancements in veterinary oncology with Ashley Kalinauskas, CEO of Torigen. Learn how personalized cancer vaccines are revolutionizing pet cancer treatment by using a pet’s own tumor cells. This episode of Vetsplanation delves into the science behind these innovative vaccines and their impact on thousands of pets. Don’t miss this insightful discussion on the future of veterinary medicine.In this episode you will learn:How personalized cancer vaccines for pets are developedThe science behind using a pet's own tumor cells for treatmentTypes of cancers targeted by Tori...2024-06-1821 min
Progress, Potential, and Possibilities Podcast / ShowAshley Kalinauskas - Founder & CEO, Torigen Pharmaceuticals - Providing Hope For Animals With CancerSend us a textAshley Kalinauskas is the Founder and CEO of Torigen Pharmaceuticals ( https://www.torigen.com/ ), a company dedicated to researching and developing novel immuno-oncology products and services specifically for the veterinary market, with a focus on autologous cancer vaccines. Torigen Pharmaceuticals is a start‑up that resulted from Ashley’s graduate thesis project at the University of Notre Dame, as she was working on her Masters in Engineering, Science and Technology Entrepreneurship in collaboration with Dr. Mark Suckow ( https://www.research.uky.edu/staff/mark-suckow ). Ashley also received an undergraduate degree in Veterinary Pathology and...2024-04-1839 min
Freelance to Freedom: Attract High Income Clients, Create an Expansive Mindset & Overcome Business BurnoutHow to Build a Massively Profitable Business From the Ground Up, Even with NO ExperienceHow do you build a business as a grad student with zero experience in business? And what about when you need to grow it quickly? What are some tips to getting Venture Capital funding?Ashley Kalinauskas is the founder and CEO of Torigen Pharmaceuticals, a start‑up that resulted from her graduate thesis project at the University of Notre Dame. She has helped create an affordable veterinary cancer treatment, VetiVax, and made it available commercially.In this episode you’ll learn:How to start and grow...2024-02-2752 min